J Agric Food Chem 47:10351040 [DOI] [PubMed] [Google Scholar] Folin O, Ciocalteu V (1927) On tyrosine and tryptophane determinations in proteins
The FDA itself is explicit that compounded drugs are not FDA-approved, and that it does not review compounded formulations for safety, effectiveness, or manufacturing quality before they reach a patient
3 Effects of incretins on the gastrointestinal tract Gut-released GLP-1 acts as a hormone and binds primarily to receptors in the gastrointestinal system
Problem: air bubbles in the syringe when drawing the dose Air bubbles in the syringe displace liquid, which means you draw less peptide solution than the syringe markings indicate
Management: Rotate injection sites daily
What is true is that if a product contains so-called N-nitrogenating agents (e.g.: preservatives like 2-Bromo-2-Nitropropane-1,3-Diol, 5-Bromo-5-Nitro- 1,3-Dioxane or sodium nitrate - so look out for things with nitro, nitra in the name) that together with TEA can form some not nice carcinogenic stuff (that is called nitrosamines)